Explaining COVID-19 postvaccination-related immune thrombotic thrombocytopenia: a hypothesis-generating in-silico approach

Cases that experienced COVID-19 postvaccination-related thrombosis have been reported after the first dose of ChAdOx1 nCov-19 (Vaxzevria, AstraZeneca) or Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine. These rare thrombotic events were observed within the expected vaccine-induced seroconversion...

Descripción completa

Detalles Bibliográficos
Autor principal: Konstantinou, George N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196821/
https://www.ncbi.nlm.nih.gov/pubmed/35412949
http://dx.doi.org/10.1080/21645515.2022.2050654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196821/
https://www.ncbi.nlm.nih.gov/pubmed/35412949
http://dx.doi.org/10.1080/21645515.2022.2050654

Ejemplares similares